Business

IVC Wealth Advisors LLC Sells 262 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

IVC Wealth Advisors LLC Sells 262 Shares of UnitedHealth Group Incorporated (NYSE:UNH) #IVC #Wealth #Advisors #LLC #Sells #Shares #UnitedHealth #Group #Incorporated #NYSEUNH Welcome to Americanah Blog, here is the new story we have for you today:

You Can Click Here To View Restricted Videos/Images in this Article

IVC Wealth Advisors LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 11.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,966 shares of the healthcare conglomerate’s stock after selling 262 shares during the quarter. IVC Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $1,010,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Signature Estate & Investment Advisors LLC lifted its position in UnitedHealth Group by 1.2% during the 1st quarter. Signature Estate & Investment Advisors LLC now owns 1,606 shares of the healthcare conglomerate’s stock worth $820,000 after buying an additional 19 shares in the last quarter. Steph & Co. lifted its position in UnitedHealth Group by 1.6% during the 1st quarter. Steph & Co. now owns 1,290 shares of the healthcare conglomerate’s stock worth $658,000 after buying an additional 20 shares in the last quarter. First City Capital Management Inc. lifted its position in UnitedHealth Group by 1.5% during the 1st quarter. First City Capital Management Inc. now owns 1,350 shares of the healthcare conglomerate’s stock worth $688,000 after buying an additional 20 shares in the last quarter. Griffin Asset Management Inc. lifted its position in UnitedHealth Group by 0.3% during the 1st quarter. Griffin Asset Management Inc. now owns 6,695 shares of the healthcare conglomerate’s stock worth $3,414,000 after buying an additional 21 shares in the last quarter. Finally, Physicians Financial Services Inc. lifted its position in UnitedHealth Group by 5.2% during the 1st quarter. Physicians Financial Services Inc. now owns 424 shares of the healthcare conglomerate’s stock valued at $216,000 after purchasing an additional 21 shares during the period. Institutional investors own 87.25% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,273 shares of the stock in a transaction that occurred on Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total value of $635,227.00. Following the completion of the sale, the executive vice president now owns 8,104 shares of the company’s stock, valued at approximately $4,043,896. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, CAO Thomas E. Roos sold 465 shares of the stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the sale, the chief accounting officer now owns 34,786 shares of the company’s stock, valued at approximately $18,866,882.82. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Erin Mcsweeney sold 1,273 shares of the stock in a transaction that occurred on Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total value of $635,227.00. Following the completion of the sale, the executive vice president now directly owns 8,104 shares of the company’s stock, valued at approximately $4,043,896. The disclosure for this sale can be found here. Insiders sold 140,324 shares of company stock valued at $75,086,185 in the last ninety days. 0.40% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have issued reports on UNH shares. UBS Group upped their target price on shares of UnitedHealth Group from $545.00 to $570.00 and gave the company a “neutral” rating in a research report on Thursday, July 21st. SVB Leerink upped their target price on shares of UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a research report on Monday, July 18th. Credit Suisse Group upped their target price on shares of UnitedHealth Group from $575.00 to $579.00 and gave the company an “outperform” rating in a research report on Monday, July 18th. Mizuho upped their price target on UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, August 10th. Finally, Loop Capital started coverage on UnitedHealth Group in a research note on Thursday, June 16th. They issued a “buy” rating and a $575.00 price target for the company. Three investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $585.65.

UnitedHealth Group Price Performance

NYSE UNH opened at $523.55 on Tuesday. The business has a 50 day simple moving average of $529.29 and a 200 day simple moving average of $511.99. UnitedHealth Group Incorporated has a 52-week low of $383.12 and a 52-week high of $553.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.77 and a current ratio of 0.77. The stock has a market cap of $489.72 billion, a price-to-earnings ratio of 27.34, a PEG ratio of 1.63 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping the consensus estimate of $5.24 by $0.33. The company had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business’s quarterly revenue was up 12.6% on a year-over-year basis. During the same period last year, the business earned $4.70 EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th will be paid a dividend of $1.65 per share. The ex-dividend date of this dividend is Friday, September 9th. This represents a $6.60 annualized dividend and a dividend yield of 1.26%. UnitedHealth Group’s dividend payout ratio is currently 34.46%.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Click Here To Continue Reading from Source

Related Articles

Back to top button